Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.37 (
CNPase
)
539
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Retinoic acid (RA) promotes growth and differentiation in many developing tissues but less is known about its influence on CNS regeneration. We investigated the possible involvement of RA in rat spinal cord injury (SCI) using the New York University (NYU) impactor to induce mild or moderate spinal cord contusion injury. Changes in RA at the lesion site were determined by measuring the activity of the enzymes for its synthesis, the retinaldehyde dehydrogenases (RALDHs). A marked increase in enzyme activity occurred by day 4 and peaked at days 8-14 following the injuries.
RALDH2
was the only detectable RALDH present in the control or injured spinal cord. The cellular localization of
RALDH2
was identified by immunostaining. In the noninjured spinal cord,
RALDH2
was detected in oligodendroglia positive for the markers RIP and
CNPase
. Expression was also intense in the arachnoid membrane surrounding the spinal cord. After SCI the increase in
RALDH2
was independent of the RIP- and
CNPase
-positive cells, which were severely depleted. Instead,
RALDH2
was present in a cell type not previously identified as capable of synthesizing RA, that expressed NG2 and that was negative for markers of astrocytes, oligodendroglia, microglia, neurons, Schwann cells and immature lymphocytes. We postulate that the
RALDH2
- and NG2-positive cells migrate into the injured sites from the adjacent arachnoid membrane, where the
RALDH2
-positive cells proliferate substantially following SCI. These findings indicate that close correlations exist between RA synthesis and SCI and that RA may play a role in the secondary events that follow acute SCI.
...
PMID:Retinoic acid synthesis by a population of NG2-positive cells in the injured spinal cord. 1584 83